Synapse Medicine in the news

Synapse Medicine's co-founder discussed medical software innovation alongside healthcare industry leaders on the BFM Business show Check-up Santé.

Louis Létinier, co-founder of Synapse Medicine, discussed health tech and medical leadership on BFM Business's Check-up Santé.

Synapse Medicine develops AI-driven software to secure drug prescriptions and clinical decision-making through integrated databases and generative AI.

Synapse Medicine is a medical AI startup founded by physicians to optimize drug prescriptions and secure clinical decisions.

Synapse Medicine won the 2025 My Com For Impact grand prize, securing a 320,000 euro media campaign for its AI-driven medical prescription tool.

Synapse Medicine has launched MedGPT, a sovereign French medical AI assistant based on Mistral technology that provides healthcare professionals with source-backed clinical decision support.

French healthcare must develop sovereign AI tools to maintain financial control and clinical independence from foreign technology providers.

MedGPT is a sovereign AI clinical assistant providing reliable medical answers and prescription support based on European healthcare standards.

Synapse Medicine has launched MedGPT, a sovereign medical AI assistant that outperforms ChatGPT in French medical exams and ensures regulatory compliance.

Synapse Medicine has launched MedGPT, a specialized French medical AI assistant that outperforms general models on national exams and ensures data sovereignty.

AI-driven medical software helps healthcare professionals secure prescriptions, automate medical letters, and access validated clinical data to reduce medical accidents.

Synapse Medicine launched an AI tool called Copilote to assist healthcare professionals, as announced by co-founder Louis Létinier.

Synapse Medicine is investing €14 million to enhance its prescription decision-support software using Mistral AI models.

Synapse Medicine and CompuGroup Medical are partnering to integrate AI-driven prescribing tools and personalized clinical decision support into healthcare software.

Synapse Medicine is conducting a clinical study with major U.S. hospitals to test AI-driven software for medication reconciliation and drug-risk analysis.

A medical software company raised 25 million euros to scale its medication safety platform and launch a consumer health app.

Synapse Medicine secured $28 million to expand its AI-powered medication safety platform for hospitals and telemedicine providers globally.

Synapse Medicine deployed an AI-powered public health platform to prevent dangerous self-medication during the COVID-19 pandemic.

Synapse Medicine secured $8 million in funding to scale its medication intelligence platform and enhance prescription safety within the global telemedicine and healthcare sectors.

Synapse Medicine raised 8 million dollars to expand its medication intelligence platform and prescription safety tools for the global telemedicine market.